NIPD GENETICS LAUNCHES ForeSENTIA, AN EXTENSIVE PORTFOLIO OF 7 CANCER-SPECIFIC AND 5 THERAPY-ASSOCIATED TUMOR PROFILE PANELS
February 17th 2020 Nicosia, Cyprus: NIPD Genetics has launched ForeSENTIA, an extensive portfolio of tumor profile panels that can identify genetic alterations (changes) that play important roles in cancer development. ForeSENTIA is a clinically valuable, time-sensitive and safe new-generation test, and provides the healthcare practitioner with actionable information that will improve patient care. It is built on NIPD Genetics’ powerful proprietary technology platform that has been validated in several studies and is trusted for its accuracy and precision.
Professional bodies agree that tumor profiling can help healthcare providers avoid a ‘one size fits all’ approach and instead choose targeted treatments that improve survival chances for cancer patients and spare them potential side effects from drugs that are unlikely to be beneficial.
Prof. Philippos Patsalis, Founder and CEO of NIPD Genetics, stated that “Through the identification of genetic alterations, patient therapy can be tailored to the distinct characteristics of each tumor and targeted towards the cancer’s specific genes that contribute to cancer growth and survival. The information obtained with ForeSENTIA tumor profile, will allow the doctor to determine the most appropriate treatment options, drug therapy and clinical trials that will greatly improve the clinical care of cancer patients”.
ForeSENTIA consists of an extensive portfolio of tumor profile panels. Each panel examines clinically actionable genetic alterations to provide accurate, detailed genetic analysis of the tumor sample collected during biopsy. The panels consist of two categories: i) comprehensive cancer-specific and ii) therapy-associated tumor profile panels. ForeSENTIA comprehensive tumor profile panels analyse a wide coverage of genes and multiple types of clinically relevant genetic alterations such as single nucleotide variants, insertions, deletions, translocations and copy number alterations implicated in specific cancer types. ForeSENTIA therapy-associated panels focus on genes that are frequently involved in many different cancer types, such as EGFR and BRAF, and have several approved therapies or ongoing clinical trials targeting them. Both panel categories offer indispensable prognostic value and guidance on treatment decisions.
ForeSENTIA is performed by analysing tumor tissue samples which are collected during biopsy. The patient’s doctor recommends the most appropriate ForeSENTIA panel and asks the histopathologist to send NIPD Genetics a tumor sample taken during biopsy. The sample is analysed at NIPD Genetics central laboratory without the need for the patient to undergo any further invasive procedure. The results are sent to the doctor through a secure portal within 2-3 weeks after the receipt of the sample at our laboratory.
ForeSENTIA provides the doctor with a broader understanding of the unique characteristics of each tumor, which allows for targeted and precise treatment, and better clinical decision-making for patients.
About NIPD Genetics:
NIPD Genetics is an innovative biotechnology company that designs, develops and provides advanced genetic tests for the prognosis, prevention, better clinical management and therapy of genetic diseases. NIPD Genetics consists of a talented and multidisciplinary team of world-class experts and scientists with knowledge and experience in the fields of business, molecular biology, human genetics, genomics, transcriptomics, methylomics, statistics and bioinformatics. NIPD Genetics laboratories are located in Nicosia, Cyprus and accredited by College of American Pathologists (CAP) and certified as per CLIA and ISO standards.
For more information on NIPD Genetics and ForeSENTIA, visit www.nipd.com/foresentia
NIPD Genetics values your interest in NIPD Genetics, its products and its services. NIPD Genetics takes the protection of your data seriously.
You may contact NIPD Genetics Public Company Ltd at NIPD Genetics Public Company Ltd Neas Engomis 31 Engomi, Nicosia 2409, Cyprus
NIPD Genetics Data Protection Officer can be reached at email@example.com
Type of personal information NIPD Genetics may collect through its Sites
The ways by which NIPD Genetics collects, uses or shares such information
Steps NIPD Genetics takes to protect its sites’ users personal information
This page informs you of our policies regarding the collection, use, and disclosure of personal data when you use our Sites and the choices you have associated with that data.
Type of personal information NIPD Genetics may collect through its Sites
Information Collection And Use
We collect several different types of information for various purposes to provide and improve our Sites and services to you.
While using NIPD Genetics Sites, you may be asked to provide NIPD Genetics certain personally identifiable information that can be used to contact or identify you ("Personal Information"). Personal Information that might be used to identify you includes, but is not limited to:
First name and last name
Address, State, Province, ZIP/Postal code, City
If you send us a query via our Contact us form, your email address, the content and any follow up emails are retained indefinitely.
Cookies and Usage Data
We may also collect information how the Sites are accessed and used ("Usage Data"). This Usage Data may include information such as your computer's Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Sites that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.
Tracking & Cookies Data
Cookies are files with small amount of data which may include an anonymous unique identifier. Cookies are sent to your browser from a website and stored on your device. Tracking technologies also used are beacons, tags, and scripts to collect and track information and to improve and analyze our Sites.
You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Sites.
Examples of Cookies we use:
Session Cookies. We use Session Cookies to operate our Sites.
Preference Cookies. We use Preference Cookies to remember your preferences and various settings.
Security Cookies. We use Security Cookies for security purposes.
Visitor behavior cookies. To understand how visitors use and navigate the Sites
Keyword cookies. To understand how visitors discover the Sites.
Use of Data
www.nipd.com uses the collected data for various purposes:
To provide and maintain the Sites
To notify you about changes to our Sites
To allow you to participate in interactive features of our Sites when you choose to do so
To provide customer care and support
To provide analysis or valuable information so that we can improve the Sites
To monitor the usage of the Sites
To detect, prevent and address technical issues
Transfer of Data
Your information, including personal data, may be transferred to — and maintained on — computers located outside of your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.
If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.
Disclosure of Data
NIPD Genetics complies with the protection of personal data regulation and will not sale or trade your personal data.
NIPD Genetics may disclose your personal data in the good faith belief that such action is necessary to:
To comply with a legal obligation
To protect and defend the rights or property of www.nipd.com
To prevent or investigate possible wrongdoing in connection with the Sites
To protect the personal safety of users of the Sites or the public
To protect against legal liability
Security of Data
The security of your data is important to us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.
We may employ third party companies and individuals to facilitate, maintain or operate our Sites ("Service Providers"), to provide the SItes on our behalf, to perform service-related services or to assist us in analyzing how our Sites is used.
These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.
We may use third-party Service Providers to monitor and analyze the use of our Sites.
Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our Service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.
Access to your personal data, correction, deletion, and Opting Out
You have the right to review, update or delete any of your personal data by sending a request at NIPD Genetics Personal Data Officer firstname.lastname@example.org
Links to Other Sites
We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.
Our Service does not address anyone under the age of 18 ("Children").
We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Children has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.